Clinical trial
Rebamipide for the Treatment of Xerostomia in Sjögren Syndrome
NCT01759108 is registered in ClinicalTrials.gov with University of Alexandria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rebamipide for the Treatment of Xerostomia in Sjögren Syndrome
- Lead sponsor
- University of Alexandria
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 13, 2020
- Completion date
- September 30, 2021
- Enrollment
- 55 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
improving symptoms of dry mouth in sjőgren's syndrome